Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2019 | Gimema D-Alba: chemo-free Ph+ ALL treatment

Sabina Chiaretti, MD, PhD, Sapienza University of Rome, Rome, Italy, outlines the key results from the Gimema D-Alba trial (NCT02744768), one of the first trials for newly diagnosed Philadelphia positive acute lymphoblastic leukemia (Ph+ ALL) patients in which a completely chemo-free approach was used. The utilization of a targeted and immunotherapeutic strategy involving induction with dasatinib plus steroids followed by blinatumomab This interview took place at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.